Published in Acta Leiden on January 01, 1988
Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis (2008) 1.40
Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy. Glob Cardiol Sci Pract (2012) 0.84
Genetic susceptibility to endomyocardial fibrosis. Glob Cardiol Sci Pract (2014) 0.75
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun (1993) 2.25
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med (2005) 2.10
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Can Babesia infections be used as a model for cerebral malaria? Parasitol Today (1999) 1.53
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
Murine malaria. IV. Disturbed immunological responsiveness during Plasmodium berghei infection. Exp Parasitol (1971) 1.28
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci (1996) 1.22
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
Malaria chemosuppression in pregnancy. III. Its effects on the maternal malaria immunity. Trop Geogr Med (1993) 1.09
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol (1993) 1.07
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol (1980) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci (1991) 1.00
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
Depressed malarial immunity in pregnant mice. Infect Immun (1980) 0.97
In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol (1994) 0.96
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Separation of parasitized erythrocytes from Plasmodium berghei infected mouse blood. Trans R Soc Trop Med Hyg (1977) 0.90
Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg (1990) 0.89
Malaria immunity and premunition in a Plasmodium berghei mouse model. Isr J Med Sci (1978) 0.89
Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice. Parasite Immunol (1997) 0.88
Chronic, patent Plasmodium berghei malaria in splenectomized mice. Infect Immun (1982) 0.87
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden (1992) 0.87
Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol (1987) 0.87
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest (2001) 0.86
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Parasite Immunol (1998) 0.85
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1. J Immunol (1996) 0.84
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans R Soc Trop Med Hyg (1984) 0.84
Plasmodium berghei: premunition, sterile immunity, and loss of immunity in mice. Exp Parasitol (1980) 0.84
Growth pattern of tumor xenografts in Wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin A. Int J Radiat Oncol Biol Phys (1983) 0.82
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast. Mol Biochem Parasitol (1995) 0.82
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta (1989) 0.82
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J Pharmacol Exp Ther (1999) 0.81
Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol (1989) 0.81
Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline. J Neurol Sci (1993) 0.81
Repair of sublethal damage in two human tumor cell lines grown as multicellular spheroids. Int J Radiat Oncol Biol Phys (1989) 0.80
Tissue reaction after intramuscular injection of liposomes in mice. Int J Clin Pharmacol Ther Toxicol (1992) 0.80
Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology (1985) 0.80
Histochemistry of cerebral lesions in mice infected with Plasmodium berghei. Trop Med Parasitol (1988) 0.80
Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol (1986) 0.80
Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol (1998) 0.80
A cytochemical study of cerebrovascular lesions in mice infected with Plasmodium berghei. J Neurol Sci (1991) 0.80
Plasmodium berghei: reduction of the mouse's specific lymphoproliferative response in relation to corticosterone and pregnancy. Exp Parasitol (1986) 0.79
Plasmodium falciparum: ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp Parasitol (1998) 0.79
The parenteral controlled release of liposome encapsulated chloroquine in mice. J Pharm Pharmacol (1990) 0.79
Malaria chemosuppression during pregnancy. IV. Its effects on the newborn's passive malaria immunity. Trop Geogr Med (1993) 0.79
Alcohol-induced liver injury after jejunoileal bypass operation in rats. J Hepatol (1987) 0.78
Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect Immun (1982) 0.78
Myosin A expressions in sporogonic stages of Plasmodium. Mol Biochem Parasitol (2000) 0.78
Radiosensitivity of different human tumor cells lines grown as multicellular spheroids determined from growth curves and survival data. Int J Radiat Oncol Biol Phys (1989) 0.78
Tumor xenotransplantation in Wistar rats after treatment with cyclophosphamide and total lymphoid irradiation. Radiology (1982) 0.77
Stage-specific proteins of Plasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum. Parasitol Res (1988) 0.77
The need for live parasites for long-term immunity in malaria. Acta Leiden (1991) 0.77
Immune phagocytosis of Plasmodium berghei parasites by mononuclear phagocytes. Cell Biol Int Rep (1983) 0.77
Attenuation of malaria infection, paralysis and lesions in the central nervous system by low protein diets in rats. Acta Trop (1992) 0.77
Malarial immunity in pregnant mice, in relation to total and unbound plasma corticosterone. Bull Soc Pathol Exot Filiales (1983) 0.77
Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor. Antimicrob Agents Chemother (1995) 0.77
Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups. Trop Geogr Med (1993) 0.77
Small bowel transplantation in the rat: the adverse effect of increased pressure during the flushing procedure of the graft. J Surg Res (1984) 0.76
The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta (1998) 0.76
Activated macrophages: inductors of endocard lesions in murine malaria. Cell Biol Int Rep (1983) 0.76
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob Agents Chemother (1999) 0.76
Impaired immune responsiveness in Plasmodium berghei immune mice. Parasite Immunol (1989) 0.76
Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria. Pharm Res (1989) 0.76
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice. Parasitology (1999) 0.76
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model. Leuk Lymphoma (2000) 0.76
Interleukin-1 as a possible agent for treatment of infection. Eur J Clin Microbiol Infect Dis (1993) 0.76